Science, Spoken cover image

Science, Spoken

The Race for the Next Ozempic

Jul 25, 2024
Pharmaceutical companies are in a race to develop innovative obesity drugs like GLP-1 receptor agonists. These drugs have the potential to help with weight loss and reshape the obesity treatment market.
09:22

Podcast summary created with Snipd AI

Quick takeaways

  • GLP-1 drugs aid weight loss by controlling blood sugar and appetite suppression.
  • Pharma companies are developing new anti-obesity medications targeting GLP-1 and GIP receptors.

Deep dives

Development of GLP-1 Receptor Agonists for Weight Loss

The discovery of the hormone GLP-1 in the 1980s led to the development of GLP-1 receptor agonists, such as Saxenda and Ozempic, for weight loss. These drugs not only help control blood sugar but also have the side effect of suppressing appetite, leading to weight loss. Recent advancements include newer drugs like Terzepatide and Rediutide, which have shown significant weight loss results in trials.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode